[
  {
    "ts": null,
    "headline": "Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks",
    "summary": "A deal for Becton Dickinson’s biosciences and diagnostic solutions unit puts Waters Corp. in a greater position to compete with larger life-science companies, but integration risks can’t be discounted, analysts say.",
    "url": "https://finnhub.io/api/news?id=505be939ad3ff2a4d2eef55e74ae6885a0c0636b76ff19d999be2ccae10ecc01",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752605220,
      "headline": "Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks",
      "id": 135960672,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "A deal for Becton Dickinson’s biosciences and diagnostic solutions unit puts Waters Corp. in a greater position to compete with larger life-science companies, but integration risks can’t be discounted, analysts say.",
      "url": "https://finnhub.io/api/news?id=505be939ad3ff2a4d2eef55e74ae6885a0c0636b76ff19d999be2ccae10ecc01"
    }
  },
  {
    "ts": null,
    "headline": "BD issues update to recall of Alaris & BD Alaris pump modules",
    "summary": "Becton Dickinson and Co: BD issues update to voluntary global recall of Alaris and BD Alaris pump modules serviced with legacy bezel kit assemblies BD recall of Alaris and BD Alaris pump modules...",
    "url": "https://finnhub.io/api/news?id=2d6befc8bf5722985ac1a6ce99b03a94c66645d8fc55b33fafd68f6304da8016",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752600010,
      "headline": "BD issues update to recall of Alaris & BD Alaris pump modules",
      "id": 135956672,
      "image": "",
      "related": "BDX",
      "source": "Finnhub",
      "summary": "Becton Dickinson and Co: BD issues update to voluntary global recall of Alaris and BD Alaris pump modules serviced with legacy bezel kit assemblies BD recall of Alaris and BD Alaris pump modules...",
      "url": "https://finnhub.io/api/news?id=2d6befc8bf5722985ac1a6ce99b03a94c66645d8fc55b33fafd68f6304da8016"
    }
  },
  {
    "ts": null,
    "headline": "Becton Dickinson and : BD Issues Update to Voluntary Global Recall of Alaris™ and BD Alaris™ Pump Modules Serviced with Legacy Bezel Kit Assemblies",
    "summary": "BD Issues Update to Voluntary Global Recall of Alaris™ and BD Alaris™ Pump Modules Serviced with Legacy Bezel Kit Assemblies FRANKLIN LAKES, N.J. - BD , a leading global...",
    "url": "https://finnhub.io/api/news?id=89a69ebc72a30b0e6c7177374dcf6610ffd2a44edd13f63e6b86e2c5dcbebba5",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752596525,
      "headline": "Becton Dickinson and : BD Issues Update to Voluntary Global Recall of Alaris™ and BD Alaris™ Pump Modules Serviced with Legacy Bezel Kit Assemblies",
      "id": 135956318,
      "image": "",
      "related": "BDX",
      "source": "Finnhub",
      "summary": "BD Issues Update to Voluntary Global Recall of Alaris™ and BD Alaris™ Pump Modules Serviced with Legacy Bezel Kit Assemblies FRANKLIN LAKES, N.J. - BD , a leading global...",
      "url": "https://finnhub.io/api/news?id=89a69ebc72a30b0e6c7177374dcf6610ffd2a44edd13f63e6b86e2c5dcbebba5"
    }
  },
  {
    "ts": null,
    "headline": "Waters, BD Bioscience deal ‘looks to be a good fit,’ says Stifel",
    "summary": "Waters (WAT) announced that it is combining with BD’s (BDX) Bioscience and Diagnostics business in a tax-efficient Reverse Morris Trust transaction that is valued at roughly $17.5B, marking a major strategic step for Waters, as the deal is large and transformative, Stifel analyst Daniel Arias tells investors in a research note. The move looks to be a good fit, though the size and complexity of the deal has to be acknowledged, Stifel says. Published first on TheFly – the ultimate source for real-",
    "url": "https://finnhub.io/api/news?id=f4bab64bae0b7722f77b6950969e6a456b2e93269361278021d8fcaf4306f51f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752589554,
      "headline": "Waters, BD Bioscience deal ‘looks to be a good fit,’ says Stifel",
      "id": 135960673,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "Waters (WAT) announced that it is combining with BD’s (BDX) Bioscience and Diagnostics business in a tax-efficient Reverse Morris Trust transaction that is valued at roughly $17.5B, marking a major strategic step for Waters, as the deal is large and transformative, Stifel analyst Daniel Arias tells investors in a research note. The move looks to be a good fit, though the size and complexity of the deal has to be acknowledged, Stifel says. Published first on TheFly – the ultimate source for real-",
      "url": "https://finnhub.io/api/news?id=f4bab64bae0b7722f77b6950969e6a456b2e93269361278021d8fcaf4306f51f"
    }
  },
  {
    "ts": null,
    "headline": "Waters deal adds variables to ‘clean’ story, says Jefferies",
    "summary": "Jefferies expects shares of Waters (WAT) to trade down on the combination with Beckton Dickinson (BDX) via a reverse merger trust due to the deal size and “variables added to a clean replacement cycle story.” However, longer term, Jefferies likes the merits of the deal, saying it creates real scale, which has proven effective in the space. It keeps a Buy rating on Waters, which is trading down 13% to $306.92 in morning trading. Published first on TheFly – the ultimate source for real-time, marke",
    "url": "https://finnhub.io/api/news?id=22aa67a85a74442b4fd638a441372afcd67fbc873e8c54f57107635c343a6aa5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752589519,
      "headline": "Waters deal adds variables to ‘clean’ story, says Jefferies",
      "id": 135960674,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "Jefferies expects shares of Waters (WAT) to trade down on the combination with Beckton Dickinson (BDX) via a reverse merger trust due to the deal size and “variables added to a clean replacement cycle story.” However, longer term, Jefferies likes the merits of the deal, saying it creates real scale, which has proven effective in the space. It keeps a Buy rating on Waters, which is trading down 13% to $306.92 in morning trading. Published first on TheFly – the ultimate source for real-time, marke",
      "url": "https://finnhub.io/api/news?id=22aa67a85a74442b4fd638a441372afcd67fbc873e8c54f57107635c343a6aa5"
    }
  },
  {
    "ts": null,
    "headline": "DoorDash, Southwest downgraded: Wall Street's top analyst calls",
    "summary": "DoorDash, Southwest downgraded: Wall Street's top analyst calls",
    "url": "https://finnhub.io/api/news?id=d87e84eb6b8f6fd172e66a455ebafff5d63cb33e2fafe284d429a76111518c91",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752587256,
      "headline": "DoorDash, Southwest downgraded: Wall Street's top analyst calls",
      "id": 135948434,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "DoorDash, Southwest downgraded: Wall Street's top analyst calls",
      "url": "https://finnhub.io/api/news?id=d87e84eb6b8f6fd172e66a455ebafff5d63cb33e2fafe284d429a76111518c91"
    }
  },
  {
    "ts": null,
    "headline": "BD Partners With Waters to Build High-Volume Diagnostics Leader",
    "summary": "BDX collaborates with Waters in a $17.5B deal to form a diagnostics powerhouse targeting $9B in revenues by 2030.",
    "url": "https://finnhub.io/api/news?id=4bcf5f5e012898e050ecb56885d316338fcde4dbb8ff245487958b43cb83af78",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752585120,
      "headline": "BD Partners With Waters to Build High-Volume Diagnostics Leader",
      "id": 135960676,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "BDX collaborates with Waters in a $17.5B deal to form a diagnostics powerhouse targeting $9B in revenues by 2030.",
      "url": "https://finnhub.io/api/news?id=4bcf5f5e012898e050ecb56885d316338fcde4dbb8ff245487958b43cb83af78"
    }
  },
  {
    "ts": null,
    "headline": "Becton, Dickinson and Company (BDX) Traded Down on Weak Earnings",
    "summary": "Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” second quarter 2025 investor letter. The fund underperformed its benchmark, the MSCI World Index (net), in the second quarter. A copy of the letter can be downloaded here. The largest performance contributors were industrials and financials, at the sector level, while health care and energy […]",
    "url": "https://finnhub.io/api/news?id=4d5c49ddf2f49a0047cfea7be86e085b8af41f1bb25a57a9e24d7f489d12b21b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752582558,
      "headline": "Becton, Dickinson and Company (BDX) Traded Down on Weak Earnings",
      "id": 135944208,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” second quarter 2025 investor letter. The fund underperformed its benchmark, the MSCI World Index (net), in the second quarter. A copy of the letter can be downloaded here. The largest performance contributors were industrials and financials, at the sector level, while health care and energy […]",
      "url": "https://finnhub.io/api/news?id=4d5c49ddf2f49a0047cfea7be86e085b8af41f1bb25a57a9e24d7f489d12b21b"
    }
  },
  {
    "ts": null,
    "headline": "BD Biosciences & Diagnostic Solutions and Waters to merge in $17.5bn deal",
    "summary": "The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026.",
    "url": "https://finnhub.io/api/news?id=52c12595f44501ddf9309638d8b8d7882afef0d63166a46063e2e54d131d5a4c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752576985,
      "headline": "BD Biosciences & Diagnostic Solutions and Waters to merge in $17.5bn deal",
      "id": 135943659,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026.",
      "url": "https://finnhub.io/api/news?id=52c12595f44501ddf9309638d8b8d7882afef0d63166a46063e2e54d131d5a4c"
    }
  },
  {
    "ts": null,
    "headline": "Becton, Dickinson and Company: A Solid Divestment For Its Bioscience And Diagnostics Business",
    "summary": "Becton, Dickinson's divestment enhances focus, reduces leverage, funds buybacks, and unlocks value. Read more about the M&A and why I remain bullish on BDX.",
    "url": "https://finnhub.io/api/news?id=e5fb8617d2016f1c9f9fdd05afabb3289214e4c8d382791c9c93bbc3028a3309",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752564481,
      "headline": "Becton, Dickinson and Company: A Solid Divestment For Its Bioscience And Diagnostics Business",
      "id": 135941969,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1323538000/image_1323538000.jpg?io=getty-c-w1536",
      "related": "BDX",
      "source": "SeekingAlpha",
      "summary": "Becton, Dickinson's divestment enhances focus, reduces leverage, funds buybacks, and unlocks value. Read more about the M&A and why I remain bullish on BDX.",
      "url": "https://finnhub.io/api/news?id=e5fb8617d2016f1c9f9fdd05afabb3289214e4c8d382791c9c93bbc3028a3309"
    }
  },
  {
    "ts": null,
    "headline": "Deals of the day-Mergers and acquisitions",
    "summary": "The following bids, mergers,acquisitions and disposals were reported by 0930 GMT on Tuesday: **Scandinavian property companies Pandox AB andEiendomsspar AS have agreed to buy Ireland's...",
    "url": "https://finnhub.io/api/news?id=5d84e1e71ac6b58d81ea2f9bbaf298a278ceb2e281e7f242863ca3313cbd93b3",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752557652,
      "headline": "Deals of the day-Mergers and acquisitions",
      "id": 135939349,
      "image": "",
      "related": "BDX",
      "source": "Finnhub",
      "summary": "The following bids, mergers,acquisitions and disposals were reported by 0930 GMT on Tuesday: **Scandinavian property companies Pandox AB andEiendomsspar AS have agreed to buy Ireland's...",
      "url": "https://finnhub.io/api/news?id=5d84e1e71ac6b58d81ea2f9bbaf298a278ceb2e281e7f242863ca3313cbd93b3"
    }
  },
  {
    "ts": null,
    "headline": "Q1 Rundown: BD (NYSE:BDX) Vs Other Surgical Equipment & Consumables - Diversified Stocks",
    "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - diversified stocks fared in Q1, starting with BD (NYSE:BDX).",
    "url": "https://finnhub.io/api/news?id=98966642dbc137934f0ac084dff126cdd65dcc598b18160c95bb3fa008b079e1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752550551,
      "headline": "Q1 Rundown: BD (NYSE:BDX) Vs Other Surgical Equipment & Consumables - Diversified Stocks",
      "id": 135965980,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - diversified stocks fared in Q1, starting with BD (NYSE:BDX).",
      "url": "https://finnhub.io/api/news?id=98966642dbc137934f0ac084dff126cdd65dcc598b18160c95bb3fa008b079e1"
    }
  },
  {
    "ts": null,
    "headline": "Waters: Becoming A Diversified Giant Following The Becton Diagnostics Merger",
    "summary": "Waters Corp.'s $17.5B merger with BD Biosciences aims to double revenue but raises risks. Read here for an investment analysis of WAT stock.",
    "url": "https://finnhub.io/api/news?id=6ad51a9650e3d9e1d899c0cf60839daf360c2b06f05648a318bb196f44e3f74c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752541243,
      "headline": "Waters: Becoming A Diversified Giant Following The Becton Diagnostics Merger",
      "id": 135933784,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2189337416/image_2189337416.jpg?io=getty-c-w1536",
      "related": "BDX",
      "source": "SeekingAlpha",
      "summary": "Waters Corp.'s $17.5B merger with BD Biosciences aims to double revenue but raises risks. Read here for an investment analysis of WAT stock.",
      "url": "https://finnhub.io/api/news?id=6ad51a9650e3d9e1d899c0cf60839daf360c2b06f05648a318bb196f44e3f74c"
    }
  }
]